Glaukos (GKOS) Earnings Analysis
Glaukos (GKOS) next reports earnings on 2026-07-29, consensus EPS -0.22293 USD. Last quarter (2026-04-29) it beat with EPS -0.18 USD vs -0.3 USD est (+40%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -46.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GKOS next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | -0.22293 USD |
| Revenue estimate | 0.15B |
GKOS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | -0.18 USD | -0.3 USD | +40% | Beat |
| 2026-02-17 | -0.28 USD | -0.22 USD | -27.3% | Miss |
| 2025-07-30 | -0.24 USD | -0.26 USD | +7.7% | Beat |
| 2025-04-30 | -0.22 USD | -0.33 USD | +33.3% | Beat |
| 2025-02-20 | -0.4 USD | -0.38 USD | -5.3% | Miss |
| 2024-11-04 | -0.28 USD | -0.52 USD | +46.2% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
GKOS valuation and analyst view
| Trailing P/E | -46.60 |
|---|---|
| Trailing EPS | -3.26304 USD |
| Price / book | 13.22 |
| Dividend yield | 0.00% |
| Market cap | 8.91B |
| Analyst consensus | Buy (18 buy / 5 hold / 1 sell) |
| Avg price target | 158.88 USD |
Related research pages
Frequently asked questions
When is Glaukos (GKOS)'s next earnings date?
Glaukos is next scheduled to report on 2026-07-29, with a consensus EPS estimate of -0.22293 USD and revenue estimate of 0.15B.
Did GKOS beat earnings last quarter?
In its 2026-04-29 report, GKOS posted EPS of -0.18 USD versus a -0.3 USD estimate — a beat of 40%.
What is GKOS's earnings track record?
Over the last 6 reported quarters with consensus data, GKOS beat estimates 4 times (67%).
What is GKOS's current P/E ratio and EPS?
GKOS trades at a trailing P/E of -46.60 on trailing EPS of -3.2630381579400916 USD.
What do analysts rate GKOS?
Analyst consensus is "Buy" across 24 ratings (0 strong buy, 18 buy, 5 hold, 1 sell, 0 strong sell). Average 12-month price target: 158.88 USD.